Plain-English translation of NCT05748145 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Colorectal Cancer research guide โPhase 2 โ Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
Researchers have discovered that a specific bacteria called Fusobacterium nucleatum is often found in colorectal cancer tumors and may make cancer harder to treat. This trial is testing whether metronidazole, an antibiotic that kills this bacteria, can reduce its presence in tumors when given before surgery. The goal is to see if reducing this bacteria could help improve how well cancer treatments work.
Scientists believe this particular bacteria may help cancer cells survive and resist chemotherapy, and may also weaken the immune system's ability to fight the cancer. This trial is exploring whether targeting this bacteria with the medication before surgery could improve treatment outcomes.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this trial, you would take metronidazole by mouth for 10 days before your scheduled colorectal cancer surgery. During this time, researchers will monitor you for any side effects. After surgery, they will examine your tumor tissue to measure whether the antibiotic reduced the harmful bacteria. The study involves about 40 participants total and focuses on understanding whether this simple preoperative step could make future cancer treatments more effective.
AI-generated summary from trial data ยท Jun 30, 2026 ยท Not medical advice
Switzerland